Glucagon-Like Peptide-1 (GLP-1)-Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes
出版年份 2018 全文链接
标题
Glucagon-Like Peptide-1 (GLP-1)-Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes
作者
关键词
-
出版物
ChemMedChem
Volume 13, Issue 7, Pages 662-671
出版商
Wiley
发表日期
2018-02-12
DOI
10.1002/cmdc.201700781
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A novel glucagon-like peptide-1/glucagon receptor dual agonist exhibits weight-lowering and diabetes-protective effects
- (2017) Jie Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes
- (2017) Melanie Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists
- (2017) Andreas Evers et al. JOURNAL OF MEDICINAL CHEMISTRY
- Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
- (2016) Matthias H. Tschöp et al. Cell Metabolism
- Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation
- (2016) Søren B. van Witteloostuijn et al. ChemMedChem
- Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical Trial
- (2016) Michael Nauck et al. DIABETES CARE
- Diabetes and obesity treatment based on dual incretin receptor activation: ‘twincretins’
- (2016) M. A. Skow et al. DIABETES OBESITY & METABOLISM
- Exendins and exendin analogs for diabetic therapy: a patent review (2012-2015)
- (2016) Eun Ji Park et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- All in one: Researchers create combination drugs for diabetes and obesity
- (2016) Shraddha Chakradhar NATURE MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
- (2015) William R. Strohl BIODRUGS
- Lessons learned from the clinical development of oral peptides
- (2015) Morten Asser Karsdal et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Protein–polymer conjugation—moving beyond PEGylation
- (2015) Yizhi Qi et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Peptide therapeutics: current status and future directions
- (2015) Keld Fosgerau et al. DRUG DISCOVERY TODAY
- An overview of new GLP-1 receptor agonists for type 2 diabetes
- (2015) Brian Tomlinson et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
- (2015) Jesper Lau et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of PEGylated Exendin-4 Released from Poly (Lactic-co-Glycolic Acid) Microspheres for Antidiabetic Therapy
- (2015) Sung Mook Lim et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- PEGylated Biopharmaceuticals
- (2015) Inge A. Ivens et al. TOXICOLOGIC PATHOLOGY
- GLP-1 based therapeutics: simultaneously combating T2DM and obesity
- (2015) Kristy M. Heppner et al. Frontiers in Neuroscience
- Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)
- (2014) Carol Wysham et al. DIABETES CARE
- Glucagon-like Peptide-1 (GLP-1) Analogs: Recent Advances, New Possibilities, and Therapeutic Implications
- (2014) Bikash Manandhar et al. JOURNAL OF MEDICINAL CHEMISTRY
- Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
- (2014) Kathleen M Dungan et al. LANCET
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function
- (2013) Cassandra Koole et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
- (2013) Martin Lorenz et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice
- (2013) Vishal Patel et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Future directions for peptide therapeutics development
- (2013) Allan A. Kaspar et al. DRUG DISCOVERY TODAY
- A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1, and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice
- (2013) Victor A. Gault et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The C-terminal extension of exendin-4 provides additional metabolic stability when added to GLP-1, while there is minimal effect of truncating exendin-4 in anaesthetized pigs
- (2013) L. Simonsen et al. REGULATORY PEPTIDES
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- Biodegradation and biocompatibility of PLA and PLGA microspheres
- (2012) James M. Anderson et al. ADVANCED DRUG DELIVERY REVIEWS
- Sodium Dependent Multivitamin Transporter (SMVT): A Potential Target for Drug Delivery
- (2012) Aswani Dutt Vadlapudi et al. CURRENT DRUG TARGETS
- Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
- (2012) T. M. Tan et al. DIABETES
- Unraveling oxyntomodulin, GLP1's enigmatic brother
- (2012) Alessandro Pocai JOURNAL OF ENDOCRINOLOGY
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- The structure and function of the glucagon-like peptide-1 receptor and its ligands
- (2011) Dan Donnelly BRITISH JOURNAL OF PHARMACOLOGY
- Preparation, Characterization, and Pharmacodynamics of Exenatide-Loaded Poly(DL-lactic-co-glycolic acid) Microspheres
- (2010) Bin Liu et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control
- (2010) P. Anagnostis et al. DIABETES OBESITY & METABOLISM
- Metabolism and Excretion of the Once-Daily Human Glucagon-Like Peptide-1 Analog Liraglutide in Healthy Male Subjects and Its In Vitro Degradation by Dipeptidyl Peptidase IV and Neutral Endopeptidase
- (2010) M. Malm-Erjefalt et al. DRUG METABOLISM AND DISPOSITION
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- (2009) A. Pocai et al. DIABETES
- Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes: A randomized controlled trial exploring weekly, biweekly, and monthly dosing
- (2009) J. Rosenstock et al. DIABETES CARE
- Liposomal formulations of glucagon-like peptide-1: Improved bioavailability and anti-diabetic effect
- (2009) Junko Hanato et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis
- (2008) Laurie L. Baggio et al. GASTROENTEROLOGY
- Improved peroral delivery of glucagon-like peptide-1 by site-specific biotin modification: Design, preparation, and biological evaluation
- (2007) Y YOUN EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now